Academic Journal
Q1Translational Research
About Translational Research
Translational Research is a scholarly journal published by Elsevier Inc.. SCImago 2025 lists it in Q1, with an SJR of 1.884 and H-index of 131.
Coverage: 2006-2026. Research categories: Biochemistry (medical) (Q1); Medicine (miscellaneous) (Q1); Physiology (medical) (Q1); Public Health, Environmental and Occupational Health (Q1).
Source-backed journal facts
Topics in published research
Diverse Scientific and Economic Studies; Human auditory perception and evaluation; Educational Robotics and Engineering; Marriage and Sexual Relationships; Pharmacy and Medical Practices; Liver Disease Diagnosis and Treatment.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,690.00 USD; 4,390.00 EUR; 3,750.00 GBP; 581,700.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Pivotal role of histone modifications in in vitro fertilization (IVF): Diagnostic and therapeutic perspectives
Lydia Vamvakidi, Christina Piperi
2026-12 · DOI: 10.1016/j.trsl.2026.09.018Intratracheal neomycin attenuates TBI-induced secondary brain injury via modulation of lung dysbiosis and inhibition of the NLRP3 inflammasome
Harry Jung, Dong Hyuk Youn, Hyun-Jung Kang, Sun-Wha Im et al.
2026-12 · DOI: 10.1016/j.trsl.2026.09.014The AR/ARD1/DLGAP5 axis drives oncogenesis and immune evasion via PD-L1 upregulation in androgen receptor-positive triple-negative breast cancer
Chongwu He, Bin Zhou, Jing Chen, Ruibo Tian et al.
2026-12 · DOI: 10.1016/j.trsl.2026.09.011SIRT1-mediated deacetylation of TRIM21 promotes IRF5 degradation and restrains type I interferon signatures in Sjögren’s disease
Yuhao Xuan, Danqian Cheng, Qi Xi, Lejie Sun et al.
2026-12 · DOI: 10.1016/j.trsl.2026.09.015S100A8/A9 decorated neutrophil extracellular traps contributes to endothelial cell dysfunction via impairing autophagic axis in sepsis lung injury
Mengdi Qu, Yuxin Shi, Shuainan Zhu, Changhong Miao et al.
2026-12 · DOI: 10.1016/j.trsl.2026.09.016The NOR-1/SPP1/OPN axis as a driver of abdominal aortic aneurysm
Paula Vázquez-Sufuentes, Judith Alonso, Rafael Almendra-Pegueros, Carme Ballester-Servera et al.
2026-12 · DOI: 10.1016/j.trsl.2026.09.017Masthead
2026-11 · DOI: 10.1016/s1931-5244(26)00206-9Information for Readers
2026-11 · DOI: 10.1016/s1931-5244(26)00209-4Pharmacological inhibition of CBP sensitizes breast cancer to DNA-damaging agents by compromising DNA repair and cell cycle pathways
Wafaa S. Ramadan, Iman M. Talaat, Aya Mudhafar Al-Azawi, Nadine Ibrahim et al.
2026-11 · DOI: 10.1016/j.trsl.2026.09.002Microbiota-derived tryptophol attenuates chronic stress-induced pain- and depression-like phenotypes in female mice via colonic aryl hydrocarbon receptor signaling through reduced neuroinflammation
Yueyang Xin, Shaodi Guan, Shaomeng Si, Jie Dong et al.
2026-11 · DOI: 10.1016/j.trsl.2026.08.007Metformin protects against myocardial ischemia/reperfusion injury and suppresses the Nur77–SPARCL1 inflammatory axis
Zhenhua Wu, Yunpeng Bai, Chao Chang, Yan Jiao et al.
2026-11 · DOI: 10.1016/j.trsl.2026.09.004Forsythiaside B alleviates DOX-induced myocardial injury by enhancing the interaction between HSP90AA1 and CYP1A1 to inhibit ferroptosis
Sailing Hu, Lingchun Lv, Zhouqing Huang
2026-11 · DOI: 10.1016/j.trsl.2026.08.008Therapeutic Co-targeting of oxidative phosphorylation and pyrimidine synthesis restores gemcitabine response in pancreatic ductal adenocarcinoma
Wenhui Ouyang, Jie Wang, Jie Chen, Zemin Fang et al.
2026-11 · DOI: 10.1016/j.trsl.2026.09.009Micro-vascularized multicellular pancreatic ductal adenocarcinoma (PDAC) spheroid: A novel 3D PDAC research model
Hanrong LI, Yizhou Zhang, Chuhan Ma, Lei Fu et al.
2026-11 · DOI: 10.1016/j.trsl.2026.08.010MGAT5 drives melanoma aggressiveness via TIMP1 glycosylation–dependent CD63–β1-integrin signaling
Beatriz Laís Justo, André van Helvoort Lengert, Sang Won Han, Miriam Galvonas Jasiulionis et al.
2026-11 · DOI: 10.1016/j.trsl.2026.09.012The crosstalk between PFKFB3 and RSPO2 drives sepsis-induced lung injury by coupling metabolic rewiring to macrophage inflammation
Yao Wang, Juan Zeng, Xiang Dai, Rui Peng et al.
2026-11 · DOI: 10.1016/j.trsl.2026.08.009Corrigendum to “Elevated circulating AIF1L as a cell-free RNA biomarker of preeclampsia impairs trophoblast function via mitochondrial dysregulation” [Translational Research 296 (2026) 198–212]
Yinlong Chen, Wenli Zhan, Ke Shen, Manqing Peng et al.
2026-11 · DOI: 10.1016/j.trsl.2026.09.003The role of B cell glycolysis in autoimmune diseases
Mengyao Shu, Yiman Peng, Zhiguang Zhou, Jingyue Li et al.
2026-11 · DOI: 10.1016/j.trsl.2026.09.005Regenerative medicine for neurodegenerative diseases: history, strategies, and clinical advances
Jia Li, Hongmei Duan, Peng Hao, Wen Zhao et al.
2026-11 · DOI: 10.1016/j.trsl.2026.08.005Microbiome crosstalk across oral, gut, and breast niches: implications for breast cancer diagnosis, prevention, and therapy
Rekha Koravadi Narasimhamurthy, Roopa K N, Vinay Kumar J Rajendra, Praveenkumar Shetty et al.
2026-11 · DOI: 10.1016/j.trsl.2026.09.007Reviews
Community Reviews
Version History
September 25, 2026 at 7:12 am
September 25, 2026